Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » 4. Approve the AMO 2004 Stock Incentive Plan.

This excerpt taken from the EYE 10-Q filed Aug 6, 2008.

4. Approve the AMO 2004 Stock Incentive Plan.

 

For

    29,077,338   

Against

    8,975,403   

Abstain

    48,658   

Broker Non-votes

    4,068,552   

The proposal was approved.

 

34

Table of Contents
Item 6. Exhibits

 

10.1

    Second Amendment to Credit Agreement by and among the Company, certain of the Company’s subsidiaries as guarantors, certain of the Revolving Credit Lenders party to the Credit Agreement and Bank of America, N.A., as administrative agent on behalf of itself and the Lenders party to the Credit Agreement.

10.2

    Form of Amendment to Form of Employment Agreement between Advanced Medical Optics, Inc. and those parties identified on Exhibit 10.3.

10.3

    Schedule of Parties to the Form of Amended Employment Agreement.

10.4

    Amendment to Offer Letter dated September 25, 2007 between Advanced Medical Optics, Inc. and Michael J. Lambert.

10.5

    Form of Amended and Restated Change in Control Agreement between Advanced Medical Optics, Inc. and those parties identified on Exhibit 10.6.

10.6

    Schedule of Executive Officers Party to the Form of Amended and Restated Change in Control Agreement.

10.7

    Amendment to Employment Agreement dated January 18, 2002, between Advanced Medical Optics, Inc. and James V. Mazzo.

10.8

    Amended and Restated 2004 Stock Incentive Plan (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K filed on June 4, 2008).

31.1

    Certification of James V. Mazzo pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

    Certification of Michael J. Lambert pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

    Certification of James V. Mazzo and Michael J. Lambert pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

35

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 4, 2008

 

ADVANCED MEDICAL OPTICS, INC.

/s/ MICHAEL J. LAMBERT

Michael J. Lambert

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

 

36

Table of Contents

EXHIBIT INDEX

 

10.1

    Second Amendment to Credit Agreement by and among the Company, certain of the Company’s subsidiaries as guarantors, certain of the Revolving Credit Lenders party to the Credit Agreement and Bank of America, N.A., as administrative agent on behalf of itself and the Lenders party to the Credit Agreement.

10.2

    Form of Amendment to Form of Employment Agreement between Advanced Medical Optics, Inc. and those parties identified on Exhibit 10.3.

10.3

    Schedule of Parties to the Form of Amended Employment Agreement.

10.4

    Amendment to Offer Letter dated September 25, 2007 between Advanced Medical Optics, Inc. and Michael J. Lambert.

10.5

    Form of Amended and Restated Change in Control Agreement between Advanced Medical Optics, Inc. and those parties identified on Exhibit 10.6.

10.6

    Schedule of Executive Officers Party to the Form of Amended and Restated Change in Control Agreement.

10.7

    Amendment to Employment Agreement dated January 18, 2002, between Advanced Medical Optics, Inc. and James V. Mazzo.

10.8

    Amended and Restated 2004 Stock Incentive Plan (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K filed on June 4, 2008).

31.1

    Certification of James V. Mazzo pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

    Certification of Michael J. Lambert pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

    Certification of James V. Mazzo and Michael J. Lambert pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

37

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki